Will weight loss jabs shrink or expand insurer’s bottom lines?

Ozempic Insulin injection pen for diabetics and weight loss. Woman weighs herself and holds Ozempic in her hand. Weight loss concept.

As well as the ability to shrink waistlines, Emma Ann Hughes unpicks how weight loss jabs have the power to transform the shape of the health and life insurance industry in 2025 and beyond.

As we enter a new year with dreams of a “new you” body, the media is once again awash with tales of how Ozempic, Mounjaro, and Wegovy have made the seemingly impossible dream of shedding pounds with

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

FCA stops potential ghost broker from trading

The Financial Conduct Authority has stopped Arthur Temlett, trading as Abacus Insurance Consultants, from carrying out any regulated activities, including acting as an insurance broker.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here